Global Stroke Management Market -Regional Analysis
On the basis of region, StrokeManagement Market is segmented into North America, Latin America, Europe,Asia Pacific, Middle East, and Africa. The substantial upsurge of geriatricpopulation in most of the economies is expected to drive growth of strokemanagement market. According to the United Nations Department of Economic andSocial Affairs 2015 report, between 2015 and 2030 the number of people in theworld at the age of 60 years or above is projected to increase by 56% from 901million to 1.4 billion. Moreover, over the next 15 years the number of olderpersons is expected to grow fastest in Latin America and the Caribbean with aprojection of around 71%, followed by Asia with 66%, Africa by 64%, NorthernAmerica by 41%, and Europe by 23% growth in old age population. Furthermore,Asia Pacific is the fastest growing stroke management market region due toupsurge in healthcare industry and increasing awareness for healthcare.
Stroke is a medical condition inwhich blood clot blocks the blood vessels and interrupts the blood flow to thebrain, resulting in cell death. Under the guidelines of American StrokeAssociation, there are of 3 types of strokes: ischemic stroke (an obstructionwithin blood vessel that delivers blood to the brain), hemorrhagic stroke(weakened blood vessel rapture due to high blood pressure), and transientischemic attack (identified by temporary clot). Stroke can be caused due tomedical conditions such as high blood pressure, diabetes, heart disease or lifestyle habits such as smoking, physically inactive lifestyle, alcohol abuse,obesity, and various others. Moreover, uncontrollable factors such asincreasing age, male sex, heredity, and ethnicity contribute to stroke.According to the World Health Organization (WHO), in 2015, stroke is the secondleading global cause of death after heart disease and it accounted for 11.8% oftotal deaths worldwide.
Stroke management market isdriven by advancements in technology and therapeutic along with increasingincidence of stroke and strict approval system is expected to hinder growth ofglobal stroke management market.
* The sample copy includes: Report Summary, Table of Contents,Segmentation, Competitive Landscape, Report Structure, Methodology.
Request a sample copyof this report: https://www.coherentmarketinsights.com/insight/request-sample/1483
Global Stroke Management MarketDriver
The advancements in technologyand facilities to diagnose stroke and discovery of novel drugs will drivegrowth of stroke management market. Technologies such as robotic-assistedangiography or exoskeleton soft suit for rehabilitation are the upcoming futureof stroke management market. Moreover, an idea of Mobile Stroke Treatment Units(MSTU) was introduced in Germany in 2003 and was used in Berlin for the firsttime in 2008. The Prehospital Acute Neurological Treatment and Optimization ofMedical care in Stroke Study (PHANTOM-S) in Germany reported that their MSTUsignificantly decreased stroke alert-to-treatment times from 76 minutes to 52minutes, and significantly increased thrombolysis rates from 21% to 33% with noincrease in the risk of intracerebral hemorrhage. Therefore, advancements inmobile stroke treatment units is expected to fuel growth of stroke managementmarket.
Conventional stroke treatmentaims at minimizing damage caused due to acute stroke by intravenousthrombolytics and endovascular thrombectomy, however, there is no proven curefor reversing the damage. It calls for a robust armamentarium of therapies forstroke treatment such as cell therapy, which has immense potential to propelthe market in near future. Cell therapy can be used for re-vascularizationafter stroke and for reduction of cerebral inflammation. Phase II clinicaltrials of intravenous transplantation of autologous bone-marrow stem cells havereported safety and tolerability in stroke patients. Other pending clinicaltrials such as PISCES can also be considered as future candidates for clinicalpractice. Sonothrombolysis is another approach, which uses low-frequencyultrasound waves to cause thrombosis. The prototype for sonothrombolysis deviceis been tested by North Carolina State University and has filed a patent on thetechnology. Under equipped or untrained emergency medical service provider andstrict governmental regulations on the approval of new drugs or advanceddevices are some of the factors that are likely to hinder growth of strokemanagement market.
Browse ResearchReport: https://www.coherentmarketinsights.com/ongoing-insight/stroke-management-market-1483
The narrow range of drugsavailable for the treatment of stroke offers wide options for researchorganizations and key players to excel the stroke management market bydiscovering novel drugs with less side-effects. Merger and acquisition is thekey strategy to expand the stroke management market. In May 2017, Codman Neuro,a part of Johnson & Johnson acquired Neuravi Ltd., an Irish medical devicecompany that manufactures advance revascularization device and EmboTrap is a devicemanufactured by this company. The EmboTrap platform was intended to address thecritical need for rapid restoration of blood flow in stroke patients andcombination of Neuravi’s expertise in clot research with Codman Neuro’s globalresources aims to accelerate development in the field of acute ischemic stroketreatment. Furthermore, strong therapeutic pipeline of players will enhancegrowth of stroke management market. In 2018, NuvOx Pharma’s dodecafluoropentaneemulsion (DDFPe) IV entered phase II clinical trials and DDFPe aims to deliveroxygen to hypoxic tissue of brain. Also, in 2018, DiaMedica Therapeutics Inc.announced DM199, a recombinant human tissue kallikrein, to enter phase IIclinical trial and it is expected to be a breakthrough in stroke treatment.
Global Stroke Management Market -Competitors
Other major companiescontributing to the stroke management market include Abbott Laboratories, B.Braun Melsungen AG, Boston Scientific Corporation, GE Healthcare,GlaxoSmithKline Plc, Medtronic Plc, Merck & Co., Inc., and Cardinal Health.
Buy-Now this researchreport: https://www.coherentmarketinsights.com/insight/buy-now/1483
AboutCoherent Market Insights:
CoherentMarket Insights is a prominent market research and consulting firm offeringaction-ready syndicated research reports, custom market analysis, consultingservices, and competitive analysis through various recommendations related toemerging market trends, technologies, and potential absolute dollar opportunity.
ContactUs:
mailto:sales@coherentmarketinsights.com
U.S.Office:
Name: Mr. Shah
CoherentMarket Insights 1001 4th Ave,
# 3200Seattle, WA 98154, U.S.
US : +1-206-701-6702
UK : +44-020-8133-4027
JAPAN: +050-5539-1737
